Risk of Food Supply Disruptions and Price Fluctuations Due to Infectious Diseases Affecting Livestock and Poultry
First written in FY2018. 16 of 17 entries say "Restated". Latest entry: FY2023.
0 other companies' latest entry also says "Restated".
- FY2023RestatedAnnual report
「Products sold by the Group that use livestock or poultry as ingredients may affect the Group's operating results due to economic and social factors, including supply disruptions, surging market prices and sluggish consumption resulting from heightened consumer concern, due to infectious diseases such as avian influenza and BSE in production areas and elsewhere.」
The Company reiterates the risks of supply disruptions, price surges and sluggish consumption due to infectious diseases affecting livestock and poultry as business and other risks for the full fiscal year. - FY2023-Q3RestatedAnnual report
「During the current third-quarter consolidated cumulative period, no new business or other risks arose. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The Company states that there have been no new occurrences or material changes regarding the risk of food supply disruptions and price volatility due to livestock and poultry diseases. - FY2022RestatedAnnual report
「Products sold by the Group that use livestock or poultry as ingredients may affect the Group's operating results due to economic and social factors, including supply disruptions, surging market prices and sluggish consumption resulting from heightened consumer concern, due to infectious diseases such as avian influenza and BSE in production areas and elsewhere.」
The Company reiterates the risks of supply disruptions, price surges and sluggish consumption due to infectious diseases affecting livestock and poultry as business and other risks for the full fiscal year. - FY2022-Q3RestatedAnnual report
「During the current third-quarter consolidated cumulative period, no new business or other risks arose. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The Company states that there have been no material changes regarding the risk of food supply disruptions and price volatility due to livestock and poultry diseases. - FY2022-Q2RestatedAnnual report
「During the current second-quarter consolidated cumulative period, no new business or other risks arose. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The Company states that there have been no material changes regarding the risk of food supply disruptions and price volatility due to livestock and poultry diseases. - FY2021RestatedAnnual report
「Products sold by the Group that use livestock or poultry as ingredients may affect the Group's operating results due to economic and social factors, including supply disruptions, surging market prices and sluggish consumption resulting from heightened consumer concern, due to infectious diseases such as avian influenza and BSE in production areas and elsewhere.」
The Company reiterates the risks of supply disruptions, price surges and sluggish consumption due to infectious diseases affecting livestock and poultry as business and other risks for the full fiscal year. - FY2021-Q3RestatedAnnual report
「During the current third-quarter consolidated cumulative period, no new business or other risks arose. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The Company states that there have been no material changes regarding the risk of food supply disruptions and price volatility due to livestock and poultry diseases. - FY2021-Q2RestatedAnnual report
「During the current second-quarter consolidated cumulative period, no new business or other risks arose. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The Company states that there have been no material changes regarding the risk of food supply disruptions and price volatility due to livestock and poultry diseases. - FY2021-Q1RestatedAnnual report
「During the current first-quarter consolidated cumulative period, no new business or other risks arose. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The Company states that there have been no material changes regarding the risk of food supply disruptions and price volatility due to livestock and poultry diseases. - FY2020-Q3RestatedAnnual report
「During the current third-quarter consolidated cumulative period, no new business or other risks arose. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The Company states that there have been no new occurrences or material changes regarding the risk of food supply disruptions and price volatility due to livestock and poultry diseases. - FY2020-Q2RestatedAnnual report
「During the current second-quarter consolidated cumulative period, no new business or other risks arose. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The Company states that there have been no new occurrences or material changes regarding the risk of food supply disruptions and price volatility due to livestock and poultry diseases. - FY2020-Q1RestatedAnnual report
「During the current first-quarter consolidated cumulative period, no new business or other risks arose. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The Company states that there have been no new occurrences or material changes regarding the risk of food supply disruptions and price volatility due to livestock and poultry diseases. - FY2019RestatedAnnual report
「Products sold by the Group that use livestock or poultry as ingredients may be affected by economic and social factors, including supply disruptions, surging market prices and sluggish consumption resulting from heightened consumer concern, due to infectious diseases such as avian influenza and BSE in production areas and elsewhere.」
The Company reiterates the risks of supply disruptions, price surges and sluggish consumption due to infectious diseases affecting livestock and poultry as business and other risks for the full fiscal year. - FY2019-Q3RestatedAnnual report
「During the current third-quarter consolidated cumulative period, no new business or other risks arose. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The Company states that there have been no new occurrences or material changes regarding the risk of food supply disruptions and price volatility due to livestock and poultry diseases. - FY2019-Q2RestatedAnnual report
「During the current second-quarter consolidated cumulative period, no new business or other risks arose. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The Company states that there have been no new occurrences or material changes regarding the risk of food supply disruptions and price volatility due to livestock and poultry diseases. - FY2019-Q1RestatedAnnual report
「During the current first-quarter consolidated cumulative period, no new business or other risks arose. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The Company states that there have been no new occurrences or material changes regarding the risk of food supply disruptions and price volatility due to livestock and poultry diseases. - FY2018First statedAnnual report
「Products sold by the Group that use livestock or poultry as ingredients may be affected by economic and social factors, including supply disruptions, surging market prices and sluggish consumption resulting from heightened consumer concern, due to infectious diseases such as avian influenza and BSE in production areas and elsewhere.」
The Company states that infectious diseases affecting livestock and poultry may impact performance through supply disruptions, surging market prices and sluggish consumption.